Cognition and dementia in Type 2 diabetes: brain imaging correlates and metabolic and vascular risk factors

Aging Health ◽  
2007 ◽  
Vol 3 (3) ◽  
pp. 361-373 ◽  
Author(s):  
Audrey M Tiehuis ◽  
Esther van den Berg ◽  
L Jaap Kappelle ◽  
Geert Jan Biessels
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Brain Imaging ◽  
Vascular Risk Factors ◽  
Vascular Risk

2079-P: Association of Serum FAM19A5 with Metabolic and Vascular Risk Factors in Human Subjects With or Without Type 2 Diabetes

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2079-P
Author(s):  
YOU-BIN LEE ◽  
JUNG A. KIM ◽  
EUN ROH ◽  
SO-HYEON HONG ◽  
KYUNG MOOK CHOI ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Human Subjects ◽  
Vascular Risk Factors ◽  
Vascular Risk

Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes

2015 ◽  
Vol 11 (02) ◽  
pp. 110
Author(s):  
Abd A Tahrani ◽  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Vascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Vascular Risk Factors ◽  
Vascular Risk ◽  
Obstructive Sleep ◽  
The Impact

Obstructive sleep apnoea (OSA) is common and is associated with many vascular risk factors, such as hypertension, insulin resistance, albuminuria, dyslipidaemia, increased inflammation and endothelial dysfunction. Epidemiological studies have shown that OSA is associated with increased cardiovascular disease (CVD) and that continuous positive airway pressure (CPAP) might reduce CVD events in patients with OSA. In addition, OSA has also been shown to be associated with albuminuria, chronic kidney disease, a wide range of ocular diseases and peripheral neuropathy. Considering that CVD and microvascular complications are major contributors to the morbidity, mortality and the economic burden of diabetes and that OSA is common in patients with type 2 diabetes (T2D), it is important to understand the role of OSA in the development and/or progression of vascular disease in patients with T2D and to explore the impact of CPAP on diabetes-related vascular outcomes. The purpose of this article is to review the evidence for the relationship and impact of OSA on vascular disease and vascular risk factors particularly in patients with T2D.

scholarly journals Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes

2015 ◽  
Vol 11 (2) ◽  
pp. 81 ◽  
Author(s):  
Abd A Tahrani ◽  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Vascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Vascular Risk Factors ◽  
Vascular Risk ◽  
Obstructive Sleep ◽  
The Impact

Obstructive sleep apnoea (OSA) is common and is associated with many vascular risk factors, such as hypertension, insulin resistance, albuminuria, dyslipidaemia, increased inflammation and endothelial dysfunction. Epidemiological studies have shown that OSA is associated with increased cardiovascular disease (CVD) and that continuous positive airway pressure (CPAP) might reduce CVD events in patients with OSA. In addition, OSA has also been shown to be associated with albuminuria, chronic kidney disease, a wide range of ocular diseases and peripheral neuropathy. Considering that CVD and microvascular complications are major contributors to the morbidity, mortality and the economic burden of diabetes and that OSA is common in patients with type 2 diabetes (T2D), it is important to understand the role of OSA in the development and/or progression of vascular disease in patients with T2D and to explore the impact of CPAP on diabetes-related vascular outcomes. The purpose of this article is to review the evidence for the relationship and impact of OSA on vascular disease and vascular risk factors particularly in patients with T2D.

scholarly journals Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes: The Fremantle Diabetes Study

Diabetes Care ◽  
2005 ◽  
Vol 28 (4) ◽  
pp. 771-776 ◽  
Author(s):  
R. M. Clifford ◽  
W. A. Davis ◽  
K. T. Batty ◽  
T. M.E. Davis
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Pharmaceutical Care ◽  
Care Program ◽  
Vascular Risk Factors ◽  
Vascular Risk

scholarly journals Association of serum FAM19A5 with metabolic and vascular risk factors in human subjects with or without type 2 diabetes

2019 ◽  
Vol 16 (6) ◽  
pp. 530-538 ◽  
Author(s):  
You-Bin Lee ◽  
Hwan-Jin Hwang ◽  
Jung A Kim ◽  
Soon Young Hwang ◽  
Eun Roh ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Human Subjects ◽  
Glycated Haemoglobin ◽  
Vascular Risk ◽  
Waist To Hip Ratio

Objectives: A recent experimental study revealed that family with sequence similarity 19 [chemokine (C-C motif)-like] member A5 (FAM19A5), a novel secreted adipokine, has inhibitory effects on vascular smooth muscle cell proliferation and migration, and on neointima formation in injured arteries. We investigated the associations between serum FAM19A5 concentration and cardio-metabolic risk factors for the first time in human subjects. Methods: Circulating FAM19A5 concentrations and their associations with cardio-metabolic risk factors were explored in 223 individuals (45 without diabetes and 178 with type 2 diabetes). Results: Serum FAM19A5 concentrations (pg/mL) were greater in patients with type 2 diabetes [median (interquartile range), 172.70 (116.19, 286.42)] compared with non-diabetic subjects [92.09 (70.32, 147.24)] ( p < 0.001). Increasing serum FAM19A5 tertile was associated with trends of increasing waist-to-hip ratio, fasting plasma glucose, glycated haemoglobin and mean brachial-ankle pulse wave velocity. Serum FAM19A5 was positively correlated with waist circumference, waist-to-hip ratio, alanine aminotransferase, fasting plasma glucose, glycated haemoglobin and mean brachial-ankle pulse wave velocity. Multiple stepwise regression analyses identified waist-to-hip ratio, low-density lipoprotein cholesterol and brachial-ankle pulse wave velocity as determining factors for log-transformed serum FAM19A5 concentration (R2 = 0.0689). Conclusion: A novel adipokine FAM19A5 was related to various metabolic and vascular risk factors in humans, suggesting its potential as a biomarker of cardio-metabolic disease.

Sign in / Sign up

Export Citation Format

Share Document